For the year ending 2025-12-31, PLRX has $225,228K in assets. $44,023K in debts. $45,445K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 45,445 | |||
| Short-term investments | 145,499 | |||
| Prepaid expenses and other current assets (note 5) | 4,464 | |||
| Property and equipment held for sale (note 4) | 1,040 | |||
| Total current assets | 196,448 | |||
| Property and equipment, net (note 4) | 2,940 | |||
| Operating lease right-of-use assets | 23,966 | |||
| Restricted cash | 1,482 | |||
| Other non-current assets | 392 | |||
| Total assets | 225,228 | |||
| Accounts payable | 480 | |||
| Accrued research and development | 4,804 | |||
| Accrued liabilities (note 6) | 9,634 | |||
| Lease liabilities, current | 1,447 | |||
| Total current liabilities | 16,365 | |||
| Lease liabilities, non-current | 27,658 | |||
| Long-term debt (note 7) | 0 | |||
| Total liabilities | 44,023 | |||
| Common stock, 0.0001 par value 300,000,000 shares authorized at december 31, 2025 and 2024 and 61,449,290 and 60,860,838 shares issued and outstanding at december 31, 2025 and december31, 2024, respectively | 6 | |||
| Additional paid-in capital | 1,040,610 | |||
| Accumulated deficit | -859,396 | |||
| Accumulated other comprehensive (loss) gain | -15 | |||
| Total stockholders equity | 181,205 | |||
| Total liabilities and stockholders equity | 225,228 | |||
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)